Inflammation and cancer
- PMID: 12490959
- PMCID: PMC2803035
- DOI: 10.1038/nature01322
Inflammation and cancer
Abstract
Recent data have expanded the concept that inflammation is a critical component of tumour progression. Many cancers arise from sites of infection, chronic irritation and inflammation. It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration. In addition, tumour cells have co-opted some of the signalling molecules of the innate immune system, such as selectins, chemokines and their receptors for invasion, migration and metastasis. These insights are fostering new anti-inflammatory therapeutic approaches to cancer development.
Figures
Comment in
-
Poetic pride in steps towards knowledge.Nature. 2003 Apr 10;422(6932):559. doi: 10.1038/422559c. Nature. 2003. PMID: 12686970 No abstract available.
Similar articles
-
The chemokine system in cancer biology and therapy.Cytokine Growth Factor Rev. 2010 Feb;21(1):27-39. doi: 10.1016/j.cytogfr.2009.11.007. Epub 2009 Dec 8. Cytokine Growth Factor Rev. 2010. PMID: 20004131 Review.
-
Proprotein convertases: Key players in inflammation-related malignancies and metastasis.Cancer Lett. 2020 Mar 31;473:50-61. doi: 10.1016/j.canlet.2019.12.027. Epub 2019 Dec 30. Cancer Lett. 2020. PMID: 31899298 Free PMC article. Review.
-
Inflammatory chemokines in cancer growth and progression.Eur J Cancer. 2006 Apr;42(6):760-7. doi: 10.1016/j.ejca.2006.01.002. Epub 2006 Feb 28. Eur J Cancer. 2006. PMID: 16510278 Review.
-
Inflammation in epithelial skin tumours: old stories and new ideas.Eur J Cancer. 2006 Apr;42(6):735-44. doi: 10.1016/j.ejca.2006.01.014. Epub 2006 Mar 9. Eur J Cancer. 2006. PMID: 16527478 Review.
-
Acetamides: chemotherapeutic agents for inflammation-associated cancers.J Chemother. 2016 Aug;28(4):255-65. doi: 10.1179/1973947815Y.0000000060. J Chemother. 2016. PMID: 26198312 Review.
Cited by
-
Microbiota in tumors: new factor influencing cancer development.Cancer Gene Ther. 2024 Sep 28. doi: 10.1038/s41417-024-00833-0. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39342031 Review.
-
Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals.World J Urol. 2024 Sep 26;42(1):538. doi: 10.1007/s00345-024-05241-5. World J Urol. 2024. PMID: 39325178
-
Contribution of PKS+ Escherichia coli to colon carcinogenesis through the inhibition of exosomal miR-885-5p.Heliyon. 2024 Sep 2;10(18):e37346. doi: 10.1016/j.heliyon.2024.e37346. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315148 Free PMC article.
-
Antitumor properties of griseofulvin and its toxicity.Front Pharmacol. 2024 Sep 3;15:1459539. doi: 10.3389/fphar.2024.1459539. eCollection 2024. Front Pharmacol. 2024. PMID: 39314753 Free PMC article. Review.
-
Inflammatory Modulation Effects of Probiotics: A Safe and Promising Modulator for Cancer Prevention.Curr Microbiol. 2024 Sep 23;81(11):372. doi: 10.1007/s00284-024-03901-8. Curr Microbiol. 2024. PMID: 39312034 Review.
References
-
- Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. - PubMed
-
- Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–1659. - PubMed
-
- Dranoff G. Tumour immunology: immune recognition and tumor protection. Curr Opin Immunol. 2002;14:161–164.
-
- Pardoll DM. Spinning molecular immunology into successful immunotherapy. Nature Rev Immunol. 2002;2:227–238. - PubMed
-
- Chettibi S, Ferguson MWJ. In: Inflammation: Basic Principles and Clinical Correlates. Gallin JI, Snyderman R, editors. Lipincott, Williams and Wilkinson; Philadelphia: 1999. pp. 865–881.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources